FDA Investigator Vashti E Bocker

Vashti E Bocker has inspections in 1 countries as of 27 Oct 2023. Vashti E Bocker has collaborated with a combinined 3232 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
46
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100001798
Country:
United States of America
Co-Investigator(s):
A Williams, Ademola O Daramola, Alan P Kurtzberg, Alexandra B Pitkin, Amalia C Himaya, Amanda L Fyles, Amir Alavi, Ana Djurdjevic, Anderson, Andrew K Haack, PhD, Angela Shepas, Arsen Karapetyan, Babajide Michael Osunsanmi, Bichsa T Tran, Binh T Nguyen, Brian P Putz, Bryan A Galvez, Carla J Lundi, Carolina D Vasquez, Carr Sharpe, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Celena Ngo, Charlotte P Chang, Chelsea N Sealey, Christina D Mello, Christopher D Washington, Christopher J Freebairn, Christopher M Jenner, Comyar Shoghi, Creighton T Tuzon, Cynthia Jim, CSO, Cynthia L Gorveatt, Daniel W Cline, Darren S Brown, Darrin E Davis, David G Whitman, Davis, Deborah A Greco, Deborah W Hsu, Dejon N Harris, Desiree C Iya, Diane Cvan Leeuwen, Dogbeda F Mackenzie, Donna Ltartaglino Besone, Dr. Chunchang Fang, Dr. Mark J Seaton, PhD, Durell L Giles, Dyana K Stone, Eileen A Liu, Eileen T Dupont, Elaine S Chow, Ellen N Stewart, Evelyn Wong, F Alex Slizza, Finn A Slizza, Francisco, Frederick L Fricke, Gabriel Craig, Garrad R Poole, Gavin T Cua, Gene D Arcy, Geoffrey M Leist, Grace P Santos, Greg K Keshishyan, Heidy C Perales, Hinh T Nguyen, Hoover, Hung H Do, MS, Jai P Singh, James A Barreto, James P Stumpff, James R Fleckenstein, Jeff M Uriarte, Jeffery A Johnson, Jennifer M Gogley, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joe X Phillips, Joel D Hustedt, Joey V Quitania, John A Gonzalez, John L Stevens, Jolanna A Norton, Joseph C Yen, Joseph S Ndu, Juanita Banuelos, Judy C Nepsa, Ka L Wong, Karen A Wolnik, Kari M Johansen, Katherine E Jacobitz, Keith P Iams, Kelley, Kelvin Cheung, Kelvin X Sanders, Kevin N Tran, Kevin T Gerrity, Kham Phommachanh, Khanh T Van, Kim Lthomas Cruse, Kimberly M Lichter, Kirtida Patel, Lakecha N Lewis, Langer, Laurissa S Flowers, Leonard H Lavi, Leticia I Romero, Lilly O Barton, Liming Zhang, Linda L Ng, Linda M Cheny, Linda Thai, Lisa Shin, Lynette M Terry, Marco S Esteves, Marcus F Yambot, Marie T Falcone, Mariza M Jafary, Mark C Saale, Matthew J Gretkierewicz, Michael D Garcia, Michael S Call, Michael T Cyrus, Michelle J Hines, Miguel A Martinez, Mihaly S Ligmond, Minh D Phan, Natalie J Ayoub, Natalie J Reese, Naveen B Walker, Nicholas L Hunt, Omotunde O Osunsanmi, Paquita F Segarra, Phillip L Toy, Rabin N Ghoshal, Richard A Abate, Richard W Tubb, Richmond K Yip, Robert C Hoover, Rumany C Penn, PharmD, Ryan J Borges, Saied A Asbagh, Samuel A Francis, Santiago Gallardo Johnson, Sara Jdent Acosta, Scott N Lim, Sean P Desbrow, Selene T Torres, Shaquenta Y Perkins, Sherrie M La, Sonya L Karsik, State Agency, Steven E Porter, Jr, Sumit Sen, Sundy Ven, Susanna N Choi, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tara L Stockton, Tawny L Colling, Teresa T Cain, Terrance L Thomas, Terri L Dodds, Thanh M Andrews, Thao T Kwan, That T Kwan, Theresa Kirkham (NMI), Trudy R Papson, Truong Xuan Nguyen (Andy), Trushani T Desai, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vickie L Anderson, Vioela J Caze, Virgilio F Pacio, CSO, Walden H Lee, William J Leonard, William S Vitale, Yasamin Ameri, Yi Lin, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne C Wilkes, Yvonne T Lacour, Zachary A Bogorad, Zachary L Miller

Vashti E Bocker's Documents

Publish Date Document Type Title
May, 2012 FDA 483 Capco Custom Packaging Inc - Form 483, 2012-05-18
January, 2012 FDA 483 Response Gary J. Schiller, MD - Form 483R, 2012-01-12
August, 2012 FDA 483 Response Andrew Schreiber - Form 483R, 2012-08-14
March, 2011 FDA 483 Irenda Corporation - Form 483, 2011-03-04
March, 2012 FDA 483 GMP Laboratories of America Inc - Form 483, 2012-03-29
April, 2012 FDA 483 Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483, 2012-04-16
August, 2011 FDA 483 Vita-Herb Nutriceuticals - Form 483, 2011-08-30
January, 2012 FDA 483 Gary J. Schiller, MD - Form 483, 2012-01-05
January, 2011 FDA 483 Old Fashioned Natural Products Inc - Form 483, 2011-01-13
October, 2011 FDA 483 MICRO CONNECTION ENTERPRISES, INC., THE - Form 483, 2011-10-28
August, 2010 FDA 483 P & L Development, LLC - Form 483, 2010-08-12
September, 2010 FDA 483 World Club Supply Corp - Form 483, 2010-09-03
December, 2013 EIR Allergan Sales, LLC - EIR, 2013-12-23
August, 2012 EIR Andrew Schreiber - EIR, 2012-08-03
February, 2012 FDA 483 I Shay Cosmetics, Inc. - Form 483, 2012-02-21
August, 2012 FDA 483 Andrew Schreiber - Form 483, 2012-08-03
January, 2011 FDA 483 MICRO CONNECTION ENTERPRISES, INC., THE - Form 483, 2011-01-05
April, 2010 FDA 483 Nexgen Pharma, Inc. - Form 483, 2010-04-02
January, 2012 EIR Gary J. Schiller, MD - EIR, 2012-01-05
July, 2011 FDA 483 Universal Supplement, Inc. - Form 483, 2011-07-29
July, 2011 FDA 483 Shine & Pretty (USA), Corp - Form 483, 2011-07-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more